Rx

Business briefs: Mayo Clinic, GSK, Lundbeck, Biogen Idec

Mayo Clinic says 70% of adults are on an Rx, with 25% of older women on an anti-depressant; GSK sinks $24M into rare-disease venture fund; Lundbeck restructures, and may kill 50 jobs; and Tecfidera is reportedly on-track for blockbuster sales estimates but still faces reimbursement hurdles.

Email Newsletters

MM&M inVISION